The aim of this study was to explore the relationship between TKa, systemic inflammation and survival in ICI-treated melanoma patients.<h4>Materials and methods</h4>Fifty-eight patients with unresectable metastatic melanoma who received anti-programmed cell death protein 1 monotherapy were included in the study. The gene discussed is PDCD1; the disease is melanoma.